A detailed history of Erste Asset Management Gmb H transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 235,800 shares of OCUL stock, worth $1.71 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
235,800
Previous 235,800 -0.0%
Holding current value
$1.71 Million
Previous $2.05 Billion 2.76%
% of portfolio
0.02%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $1.52 Million - $2.18 Million
235,800 New
235,800 $2.05 Billion
Q4 2023

Nov 26, 2024

BUY
$2.08 - $4.52 $160,160 - $348,039
77,000 Added 48.49%
235,800 $1.07 Billion
Q1 2023

Nov 26, 2024

BUY
$2.79 - $6.27 $175,770 - $395,010
63,000 Added 65.76%
158,800 $819 Million
Q4 2022

Nov 26, 2024

BUY
$2.61 - $4.41 $164,430 - $277,830
63,000 Added 65.76%
158,800 $445 Million
Q3 2022

Nov 26, 2024

SELL
$4.09 - $6.5 $572,600 - $910,000
-140,000 Reduced 59.37%
95,800 $491 Million
Q2 2022

Nov 26, 2024

SELL
$3.01 - $5.22 $421,399 - $730,800
-140,000 Reduced 59.37%
95,800 $373 Million
Q4 2021

Nov 22, 2024

SELL
$6.16 - $12.07 $862,400 - $1.69 Million
-140,000 Reduced 59.37%
95,800 $632 Million
Q3 2021

Nov 22, 2024

BUY
$9.7 - $14.34 $252,199 - $372,840
26,000 Added 37.25%
95,800 $971 Million
Q1 2021

Nov 22, 2024

BUY
$15.82 - $22.11 $281,596 - $393,558
17,800 Added 34.23%
69,800 $1.12 Billion
Q4 2020

Nov 22, 2024

SELL
$7.91 - $22.95 $1.45 Million - $4.22 Million
-183,800 Reduced 77.95%
52,000 $1.04 Billion

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $558M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.